Press-release for stocks related to pharma

tags : Pharma crawled time : 08:00

save search

Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 1.4K

Health Technology

| -2.31% | O: -0.02% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -4.0% | O: -1.51% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| 0.84% | O: 0.84% H: 4.56% C: 0.83%
pharma conference

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M

Health Technology

| -6.71% | O: 1.77% H: 0.05% C: -0.93%
pharma company astrazeneca acquired agreement

BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
Published: 2024-03-04 (Crawled : 08:00) - bridgebio.com
BBIO | $25.12 0.56% 500K

Health Technology

| -29.16% | O: 0.93% H: 0.08% C: -10.03%
pharma agreement

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 1.4K

Health Technology

| -7.51% | O: 1.62% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -7.89% | O: 1.12% H: 0.93% C: 0.77%
IPHA | $2.41 11K

Health Technology

| -13.31% | O: 6.47% H: 3.65% C: -2.36%
fda pharma program

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $123.37 -0.93% 1.4M

Health Technology

| 25.81% | O: 0.91% H: 0.72% C: 0.11%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -4.83% | O: 0.45% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| -1.63% | O: 13.88% H: 0.0% C: -3.58%
pharma natural cell sanofi

Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300

Health Technology

| 11.81% | O: 9.45% H: 0.0% C: -1.7%
SNYNF | News | $92.7 1.4K

Health Technology

| -0.54% | O: 0.5% H: 1.67% C: 0.1%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -0.22% | O: 2.15% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| -6.59% | O: -1.16% H: 0.39% C: -4.31%
sar4435 pharma iph6101 cell results sanofi

Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
Published: 2023-12-04 (Crawled : 08:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
obesity pharma pipeline

Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
LLY | News | $745.46 -0.71% 940K

Health Technology

| 26.93% | O: -0.01% H: 0.81% C: -0.07%
FGEN | $1.26 -0.79% 400K

Health Technology

| 154.71% | O: 6.3% H: 11.13% C: 4.23%
pharma

Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| 0.95% | O: -1.32% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| -7.31% | O: -2.31% H: 2.76% C: 1.18%
pharma conference business update

Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 1.4K

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -13.23% | O: -15.73% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| -2.03% | O: -2.85% H: 12.13% C: 3.77%
pharma

Innate Pharma Provides Update on Lacutamab Clinical Program
Published: 2023-10-05 (Crawled : 08:00) - biospace.com/
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -14.41% | O: 0.19% H: 0.0% C: 0.0%
IPHA | $2.41 11K

Health Technology

| -2.43% | O: -9.31% H: 7.14% C: 7.14%
pharma update program

Innate Pharma Reports First Half 2023 Financial Results and Business Update
Published: 2023-09-14 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 1.4K

Health Technology

| -13.74% | O: 2.14% H: 0.0% C: -1.3%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -14.97% | O: 0.26% H: 0.74% C: 0.33%
IPHA | $2.41 11K

Health Technology

| -21.24% | O: -5.23% H: 6.9% C: 5.74%
pharma business update financial results

Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Published: 2023-08-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $144.54 -0.16% 4.9M

Health Technology

| -12.71% | O: -1.1% H: 0.0% C: 0.0%
RPRX | News | $27.86 0.91% 620K

Health Technology

| -6.97% | O: 0.0% H: 0.72% C: -0.4%
adstiladrin pharma pharmaceuticals royalty agreement therapy

Innate Pharma to Participate in Upcoming Investor Conference - August 10, 2023
Published: 2023-08-10 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300

Health Technology

| -8.93% | O: 3.09% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M

Health Technology

| -12.41% | O: 1.52% H: 1.05% C: 0.47%
IPHA | $2.41 11K

Health Technology

| -16.32% | O: 2.78% H: 0.68% C: 0.34%
pharma conference

Angle PLC Announces Pharma Services Contract with Artios Pharma
Published: 2023-05-25 (Crawled : 08:00) - biospace.com/
ANPCF | $0.148 641.22% 5K

Health Technology

| Email alert Add to watchlist
ANPCY | $1.98 338.38% 930

Manufacturing

| Email alert Add to watchlist
pharma services contract

Poolbeg Pharma PLC Announces Board Appointment - May 24, 2023
Published: 2023-05-24 (Crawled : 08:00) - biospace.com/
ICLR | $292.77 0.26% 310K

Health Technology

| 37.7% | O: -2.66% H: 0.9% C: 0.21%
pharma

Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-04-25 (Crawled : 08:00) - biospace.com/
VRNA | $16.19 -1.28% 210K

Health Technology

| -28.7% | O: -0.7% H: 2.41% C: -1.07%
pharma report update financial results

Angle PLC Announces Pharma Services Contract with Crescendo Biologics
Published: 2023-04-13 (Crawled : 08:00) - biospace.com/
ANPCF | $0.148 641.22% 5K

Health Technology

| Email alert Add to watchlist
ANPCY | $1.98 338.38% 930

Manufacturing

| Email alert Add to watchlist
pharma services contract